mTOR and Akt Signaling in Cancer: SGK Cycles In

Slides:



Advertisements
Similar presentations
Cost of Unneeded Proteins in E. coli Is Reduced after Several Generations in Exponential Growth Irit Shachrai, Alon Zaslaver, Uri Alon, Erez Dekel Molecular.
Advertisements

AMPK—Sensing Energy while Talking to Other Signaling Pathways
Taking the Stress out of Melanoma
A Novel ER Stress-Independent Function of the UPR in Angiogenesis
IRS-1: Auditing the effectiveness of mTOR inhibitors
Dun1 Counts on Rad53 to Be Turned On
AMPK-Dependent Phosphorylation of ULK1 Induces Autophagy
Figure 1 mTOR pathway activation
Nutrient-Sensing Mechanisms across Evolution
Guards at the Gate to Embryonic Stem Cell Differentiation
The Akt-mTOR tango and its relevance to cancer
Kinase inhibitors: Vice becomes virtue
Overgrowth Syndromes Caused by Somatic Variants in the Phosphatidylinositol 3- Kinase/AKT/Mammalian Target of Rapamycin Pathway  Gozde Akgumus, Fengqi.
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
A Novel ER Stress-Independent Function of the UPR in Angiogenesis
mTORC1: Turning Off Is Just as Important as Turning On
Deconstructing ERK Signaling in Tumorigenesis
Figure 1 mTOR complex biology
Methed-Up FOXOs Can't In-Akt-ivate
Should I Stay or Should I Go: Neuromodulators of Behavioral States
Volume 29, Issue 3, Pages (March 2016)
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
PHLPPing It off: Phosphatases Get in the Akt
Primary Cilia Bend LKB1 and mTOR to Their Will
Is REDD1 a Metabolic Éminence Grise?
Foxo1 and Foxo3 help Foxp3 Immunity
A New Link in the Chain from Amino Acids to mTORC1 Activation
A Metabolic (Re-)Balancing Act
P Bodies and the Control of mRNA Translation and Degradation
Jan Philipp Junker, Alexander van Oudenaarden  Molecular Cell 
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Volume 46, Issue 5, Pages (June 2012)
Rapamycin: One Drug, Many Effects
Taru Muranen, Funda Meric-Bernstam, Gordon B. Mills  Cancer Cell 
Eukaryotic Transcription Activation: Right on Target
Autophagy: A Potential Link between Obesity and Insulin Resistance
Autophagy in kidney disease and aging: lessons from rodent models
IRS-1: Auditing the effectiveness of mTOR inhibitors
An Emerging Role of mTOR in Lipid Biosynthesis
AMPK—Sensing Energy while Talking to Other Signaling Pathways
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
An Argonaute Protein Directs Nuclear Xrn2 Function
Russell G. Jones, Edward J. Pearce  Immunity 
AKT/PKB Signaling: Navigating the Network
Plasma Cells for Hire: Prior Experience Required
Mitochondria and Cancer
Figure 1 The mTOR signalling pathway
Insulin Action under Arrestin
AKT/PKB Signaling: Navigating Downstream
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Ophélie Meynet, Jean-Ehrland Ricci  Trends in Molecular Medicine 
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
Rapamycin: One Drug, Many Effects
Glutaminolysis Activates Rag-mTORC1 Signaling
Amino Acid Signaling to TOR Activation: Vam6 Functioning as a Gtr1 GEF
Alex Kentsis, A. Thomas Look  Cell Stem Cell 
Brian K. Kennedy, Dudley W. Lamming  Cell Metabolism 
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
TOR Regulation: Sorting out the Answers
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Christina L. Rosenberger, Jie Chen  Molecular Cell 
Autophagy and the Integrated Stress Response
Lysosomal Rag-ulation of mTOR Complex 1 Activity
Volume 63, Issue 6, Pages (September 2016)
AMPK and p53 help cells through lean times
Toward a Molecular Definition of Leucine-Dependent mTORC1 Activation
T Helper Cell Differentiation: Understanding the Needs of Hierarchy
Skp2, the FoxO1 hunter Cancer Cell
The Ribosome and TORC2: Collaborators for Cell Growth
Presentation transcript:

mTOR and Akt Signaling in Cancer: SGK Cycles In Alex Toker  Molecular Cell  Volume 31, Issue 1, Pages 6-8 (July 2008) DOI: 10.1016/j.molcel.2008.06.007 Copyright © 2008 Elsevier Inc. Terms and Conditions

Figure 1 mTOR Signaling to Akt and SGK Converge to Regulate p27 Localization Growth factors stimulate PI3K activation, which recruits PDK-1 to the membrane, leading to phosphorylation of Akt at the T-loop residue T308. PDK-1 also phosphorylates SGK at T256 in intracellular locations. Akt then phosphorylates TSC2 inhibiting its RheB GAP activity, stimulating GTP loading of RheB, which in turn potently activates mTOR in the mTORC1 complex. The rapamycin-insensitive mTORC2 complex directly phosphorylates Akt at the hydrophobic motif S473, leading to full Akt activation. The TSC complex is also required for efficient activation of TORC2. Whereas mTORC2 is required for Akt activation, mTORC1 directly phosphorylates SGK at the hydrophobic motif S422, leading to activation. Both Akt and SGK can directly phosphorylate p27 at T157, leading to impaired nuclear import and cytoplasmic retention. The AMPK pathway signals to the TSC complex and promotes mTOR activation in response to nutrients such as glucose and amino acids. The net effect is inhibition of cell-cycle progression leading to growth arrest. (Green arrows denote direct phosphorylation reactions). Molecular Cell 2008 31, 6-8DOI: (10.1016/j.molcel.2008.06.007) Copyright © 2008 Elsevier Inc. Terms and Conditions